| Pregnancy |
1 |
1 |
| Atypical Antipsychotics |
0 |
0.53 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.45 |
| Antipsychotics |
0 |
0.38 |
| Hospital |
0 |
0.38 |
| Massachusetts |
0 |
0.38 |
| Depression |
0 |
0.33 |
| Antidepressant drug |
0 |
0.25 |
| Anxiety |
0 |
0.25 |
| Lactation |
0 |
0.25 |
| Postpartum |
0 |
0.25 |
| Toxicology |
0 |
0.2 |
| Electronic Health Record (EHR) |
0 |
0.15 |
| Bipolar Disorder |
0 |
0.14 |
| Post-Traumatic Stress Disorder |
0 |
0.14 |
| Postpartum Depression |
0 |
0.14 |
| Anxiety Disorder |
0 |
0.13 |
| Bipolar Depression |
0 |
0.13 |
| Clinical Guidelines |
0 |
0.13 |
| Electronic Medical Record |
0 |
0.13 |
| Final Rule |
0 |
0.13 |
| Food and Drug Administration (FDA) |
0 |
0.13 |
| Health Policy |
0 |
0.13 |
| Prescription Drugs |
0 |
0.13 |
| SNRI |
0 |
0.13 |
| Steroids |
0 |
0.13 |
| Stress |
0 |
0.13 |
| Insomnia |
0 |
0.1 |
| Sleep Disorders |
0 |
0.1 |